This entry has been replaced by an amended Lobbying Activity Report:
2301-19167
|
Organization:
|
Novartis Pharmaceuticals Canada Inc.
|
|
Associated registration:
|
8870-2301-29
|
|
Lobbying Activity date:
|
2022-06-13
|
|
Arranged a meeting:
|
No
|
|
Posted date:
|
2022-06-14
|
| In-house lobbyists who participated in the lobbying activity: |
Geoffrey Squires
|
|
Senior Public Office Holders who were lobbied in this activity:
|
Mitch Moneo,
Assistant Deputy Minister
Pharmaceutical Laboratory & Blood Services,
Health
|
| |
Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discussions with BC government officials/organizations and elected representatives to obtain public reimbursement of Novartis' innovative treatments for BC citizens that require access to these treatments, through various BC government funded programs such as Pharmacare, Health Authorities, BC Cancer Agency, etc. And, to encourage the BC government to recognize the importance of Novartis investments in Research and Development to the development of BC's healthcare bioscience research ecosystem and to providing innovative approaches to management of the health care system.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Hospitals
|
|
| |
|
Lobbying Activity Report replaced on:
|
2022-06-14
amended entry:
2301-19167
|
| |
|
Senior officer who filed this Lobbying Activity Report:
|
Andrea Marazzi
|
| |
|
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
|